Related Experiment Video

Updated: Jun 5, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

Pathogenesis and clinical manifestations of juvenile rheumatoid arthritis

Youn-Soo Hahn1, Joong-Gon Kim

  • 1Department of Pediatrics, Chungbuk National University College of Medicine, Cheongju, Korea.

Korean Journal of Pediatrics
|January 11, 2011
PubMed

Insights

Juvenile rheumatoid arthritis (JRA) is a common childhood rheumatic disease. Proinflammatory cytokines are key drivers of JRA inflammation, supporting targeted biologic therapies.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Juvenile rheumatoid arthritis (JRA) is the most prevalent rheumatic condition in children, affecting those under 16.
  • JRA presents heterogeneously, classified into oligoarthritis, polyarthritis, and systemic onset types, each with distinct immunogenetic underpinnings.
  • Inflammation in JRA joints involves swelling, pain, heat, and functional loss, with potential extra-articular manifestations like fever, rash, and uveitis.

Purpose of the Study:

  • To elucidate the immunogenetic factors and pathomechanisms underlying JRA.
  • To differentiate the pathogenesis of systemic onset JRA from oligoarticular and polyarticular forms.
  • To highlight the role of proinflammatory cytokines in JRA pathogenesis and therapeutic strategies.

Main Methods:

  • Analysis of immunogenetic predispositions in JRA subtypes.
  • Characterization of cellular players, including T helper 1 (Th1) cells and monocytes, in synovial inflammation.
  • Evaluation of the role of proinflammatory cytokines in disease manifestation.

Main Results:

  • Oligoarticular and polyarticular JRA are linked to T helper 1 (Th1) cell-mediated inflammation and specific cytokines.
  • Systemic onset JRA exhibits a distinct pathogenesis, lacking association with human leukocyte antigen (HLA) and autoantibodies.
  • Proinflammatory cytokines are implicated in the clinical symptoms across all JRA types.

Conclusions:

  • While JRA's precise cause is unknown, proinflammatory cytokines significantly contribute to symptoms in all subtypes.
  • The efficacy of biologic therapies targeting these cytokines validates their central role in JRA pathogenesis.
  • Understanding JRA heterogeneity is crucial for developing effective, targeted treatments.

Keywords:
ChildCytokinesInflammationJuvenile arthritis

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...